1/ The “1 in a million” vaccine injury mantra of profiteers is about to be put to the test with the imminent, unprecedented roll-out of Corona vaccines...
2/ vaccine industry insiders know Corona vaccines are like playing with fire: “Another serious concern is ‘antibody-induced enhancement’ where the antibodies produced by a vaccine actually make future infections worse..” (aka, “viral interference) https://www.theguardian.com/world/2020/may/22/why-we-might-not-get-a-coronavirus-vaccine
4/ the “1 in a million” mantra was destroyed by a study at Harvard funded by the CDC, where they collated vaccine injury data in a systematic way... https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf
5/ what did they find? The study authors detected adverse events in 2.6% of those vaccinated, or 26,000 per million, which doesn’t sound quite as safe!!
6/ they also mentioned that less than 1% of vaccine adverse events are reported...
7/ And, yet, that’s only a tiny piece of the story. The iceberg below the water is something few appreciate: latent onset injury from vaccines...which are very hard to track if you refuse to acknowledge they exist...
10/ the only biological science done looking at latency of neurological onset was done by Chinese scientists in 2016: http://vaccinesafetycommission.com/pdfs/Neonatal-hepatitis-B-vaccination-impaired-the-behavior-and-neurogenesis-of-mice-transiently-in-early-adulthood..pdf
11/ they were only looking at HepB vaccine, which is often given to babies on Day 1 of life. Their conclusion should cause every parent to shudder.
13/ so, will Corona vax cause widespread injury. More than likely, yes. Will it cause injuries with a latency period? Probably. Will profiteers try to obscure all of this? You know the answer. Can we start 26,000 in a million as a new vaccine tag line? #only26kpermillion
You can follow @jb_handley.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.